Cargando…

The efficacy of anti‐programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma

BACKGROUND: Anti‐programmed cell death protein 1 (PD‐1) antibodies are a standard treatment for metastatic melanoma patients. However, the understanding of the efficacy of anti‐PD‐1 for acral melanoma (AM) and mucosal melanoma (MM) is limited as these subtypes are relatively rare compared to cutaneo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Dai, Haydu, Lauren E., Glitza, Isabella C., Patel, Sapna P., Tawbi, Hussein A., McQuade, Jennifer L., Diab, Adi, Ekmekcioglu, Suhendan, Wong, Michael K., Davies, Michael A., Amaria, Rodabe N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982611/
https://www.ncbi.nlm.nih.gov/pubmed/33686688
http://dx.doi.org/10.1002/cam4.3781